Prescription Trends for Stable Angina Management in a Tertiary Care Hospital

Abstract

Background: Stable angina is a common manifestation of coronary artery disease, requiring optimal medical management to prevent complications and improve patient outcomes. Understanding prescription patterns in a tertiary care setting can help evaluate adherence to clinical guidelines and identify areas for improvement.

Objective: This study aims to analyze the prescription trends for stable angina management in a tertiary care hospital, assessing the utilization of anti-angina agents, antiplatelet therapy, lipid-lowering drugs, and other adjunctive medications..

Methods: A cross-sectional study was conducted by reviewing medical records of stable angina patients receiving treatment at a tertiary care hospital. Data on demographic characteristics, prescribed medications, and adherence to guideline-based therapy were collected and analyzed.

Results: The study findings indicate that Anti- Platelet agents, β-blockers and calcium channel blockers were the most frequently prescribed anti-angina agents, followed by nitrates. While statins were prescribed in most cases for lipid control. A proportion of patients received additional agents such as ACE inhibitors or ARBs for cardiovascular risk reduction.

Conclusion: The prescription trends observed in this study align with established treatment guidelines for stable angina. However, variations in prescribing patterns highlight the need for continuous evaluation and reinforcement of evidence-based practices to optimize patient care. Further research is needed to assess long-term outcomes associated with different treatment strategies.